Sun Pharmaceutical Industries Limited is a global pharmaceutical company headquartered in Mumbai, India that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) primarily in India and the United States. Sun Pharma is the third largest and the most profitable pharmaceutical company in India as well as the largest pharmaceutical company by market capitalization on the Indian exchanges.
Clinquest Group, B.V. based in Amsterdam, The Netherlands, is the parent corporation of a family of companies in the US and Europe that specialize in consulting services for drug discovery and development, implementation, post-approval expertise and compound partnering programs, serving the pharmaceutical, biotechnology, biomedical device and medical data industries. Clinquest provides targeted services to local clients within the biopharmaceutical industry. The company’s clientele ranges from start-up biotech companies to fully integrated pharmaceutical organizations.
The large and well-equipped Slotervaart hospital pharmacy is responsible for all (experimental) drug design and production for both the Slotervaart Hospital and the NKI. The hospital pharmacy has long been the only Dutch institution outside the pharmaceutical industry with the facilities and authorization to perform industrial (and GMP) manufacturing of (experimental) medicinal products. Enceladus has been working together with the pharmacy regarding its pharmaceutical development activities, CMC, and IMPD documentation.
Utrecht University Holding BV is responsible for the patent portfolio and for various technology transfer activities from Utrecht University (UU) and the University Medical Center Utrecht (UMC). To date, Utrecht Holdings has started and invested in more than 30 spin out companies and currently hold equity in 20 companies.